Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.340
+0.060 (4.69%)
At close: Jun 20, 2025, 4:00 PM
1.390
+0.050 (3.73%)
After-hours: Jun 20, 2025, 7:58 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $124.63 million as of June 20, 2025. Its market cap has decreased by -36.26% in one year.
Market Cap
124.63M
Enterprise Value
-61.60M
1-Year Change
-36.26%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $124.63M, a decrease of -85.97%. That is a compound annual growth rate of -39.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 124.63M | -13.44% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.53B |
| Johnson & Johnson | 359.71B |
| Novo Nordisk | 333.14B |
| AbbVie | 325.83B |
| UnitedHealth Group | 276.25B |
| Abbott Laboratories | 230.84B |
| Novartis AG | 227.73B |
| AstraZeneca | 219.65B |